Sign in
4

Changes in Ownership

Aardvark Therapeutics, Inc. Filed Acc 0000950170-25-086145

Options or other derivatives

  • Chief Medical Officer acquired 126,999 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jaiman Manasi Chief Medical Officer 2025-06-11 Grant or award · Stock Option (right to buy) +126,999 126,999 D: show line 1 in the form
Loading xslF345X05/ownership.xml…